1134. Lenzilumab Treatment in COVID-19 Pneumonia Reduces Circulating Cytokines and Markers of Systemic Inflammation

BACKGROUND: Coronavirus disease 2019 (COVID-19) results from SARS-CoV-2-induced hyperinflammatory immune response, orchestrated by granulocyte-macrophage colony-stimulating factor (GM-CSF). GM-CSF increases interleukin-6 (IL-6) levels, ultimately leading to increased C-reactive protein (CRP). The LI...

Descripción completa

Detalles Bibliográficos
Autores principales: Chappell, Dale, Kilcoyne, Adrian, Cerasoli, Frank, Lukas, John, Durrant, Cameron, Temesgen, Zelalem, Polk, Christopher, Baker, Jason, Marconi, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752421/
http://dx.doi.org/10.1093/ofid/ofac492.973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752421/
http://dx.doi.org/10.1093/ofid/ofac492.973

Ejemplares similares